Business · 1 sources covering this

India outperformance, synergy gains to keep Torrent Pharma growth strong

Strong domestic growth, a chronic-heavy portfolio, JB Pharma integration benefits and gains in semaglutide are expected to support Torrent Pharma's near-term performance

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
India outperformance, synergy gains to keep Torrent Pharma growth strong
Strong domestic growth, a chronic-heavy portfolio, JB Pharma integration benefits and gains in semaglutide are expected to support Torrent Pharma's near-term performance
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/8fa37af9b1cfa27059347cbc5e9bfc9766cde302"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="India outperformance, synergy gains to keep Torrent Pharma growth strong"></iframe>

India outperformance, synergy gains to keep Torrent Pharma growth strong

How 1 sources are covering this

India outperformance, synergy gains to keep Torrent Pharma growth strong

More from Business

Cabinet approves eight multitracking projects to decongest railway lines

US stock market: Dow, Nasdaq, S&P 500 fall as oil tops $100, Fed rate hike bets rise

BoB CEO calls for higher investment in cyber security as threats mount

Government working to allow ethanol blending beyond E20 via flexi-fuel vehicles: Tarun Kapoor

Reader

Trust & legal

Across the network